Migraine: disease characterisation, biomarkers, and precision medicine

M Ashina, GM Terwindt, MAM Al-Karagholi, I De Boer… - The Lancet, 2021 - thelancet.com
Migraine is a disabling neurological disorder, diagnosis of which is based on clinical criteria.
A shortcoming of these criteria is that they do not fully capture the heterogeneity of migraine …

Sources of vascular nitric oxide and reactive oxygen species and their regulation

J Tejero, S Shiva, MT Gladwin - Physiological reviews, 2019 - journals.physiology.org
Nitric oxide (NO) is a small free radical with critical signaling roles in physiology and
pathophysiology. The generation of sufficient NO levels to regulate the resistance of the …

Human models of migraine—short-term pain for long-term gain

M Ashina, JM Hansen, BO á Dunga… - Nature Reviews …, 2017 - nature.com
Migraine is a complex disorder characterized by recurrent episodes of headache, and is one
of the most prevalent and disabling neurological disorders. A key feature of migraine is that …

Reactive oxygen-related diseases: therapeutic targets and emerging clinical indications

AI Casas, VTV Dao, A Daiber, GJ Maghzal… - Antioxidants & redox …, 2015 - liebertpub.com
Significance: Enhanced levels of reactive oxygen species (ROS) have been associated with
different disease states. Most attempts to validate and exploit these associations by chronic …

CGRP and NO in the trigeminal system: mechanisms and role in headache generation

K Messlinger, JK Lennerz, M Eberhardt… - … : The Journal of …, 2012 - Wiley Online Library
Calcitonin gene‐related peptide (CGRP) and metabolic products of nitric oxide (NO) are
increased in jugular venous plasma during migraine attacks and other primary headaches …

Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine …

M De Felice, MH Ossipov, R Wang, G Dussor, J Lai… - Brain, 2010 - academic.oup.com
Migraine is a common neurological disorder often treated with triptans. Triptan overuse can
lead to increased frequency of headache in some patients, a phenomenon termed …

Pearls and pitfalls in human pharmacological models of migraine: 30 years' experience

M Ashina, JM Hansen, J Olesen - Cephalalgia, 2013 - journals.sagepub.com
In vitro studies have contributed to the characterization of receptors in cranial blood vessels
and the identification of new possible anti-migraine agents. In vivo animal models enable …

Pharmacology and clinical drug candidates in redox medicine

VTV Dao, AI Casas, GJ Maghzal… - Antioxidants & redox …, 2015 - liebertpub.com
Significance: Oxidative stress is suggested to be a disease mechanism common to a wide
range of disorders affecting human health. However, so far, the pharmacotherapeutic …

Migraine, neurogenic inflammation, drug development-pharmacochemical aspects

M Lukacs, J Tajti, F Fulop, J Toldi… - Current medicinal …, 2017 - ingentaconnect.com
Background: Migraine is a primary headache disorder. Despite numerous studies conducted
with the aim to understand the pathophysiology of migraine, several aspects are still unclear …

Reactive nitroxidative species and nociceptive processing: determining the roles for nitric oxide, superoxide, and peroxynitrite in pain

JW Little, T Doyle, D Salvemini - Amino acids, 2012 - Springer
Pain is a multidimensional perception and is modified at distinct regions of the neuroaxis.
During enhanced pain, neuroplastic changes occur in the spinal and supraspinal …